Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Hard-to-treat cancers: What makes them special?

Small cell lung cancer: How molecular insights have shed light on aggressive clinical behaviour


12 Sep 2022


Hard-to-treat cancers: What makes them special?


Tumour Site

Small Cell Lung Cancer;  Neuroendocrine Neoplasms


Charles Rudin


C.M. Rudin

Author affiliations

  • Department Of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 - New York/US


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.